{
    "clinical_study": {
        "@rank": "156479", 
        "arm_group": {
            "arm_group_label": "Chronic kidney disease, stage 5"
        }, 
        "brief_summary": {
            "textblock": "Studies suggest that dietary omega-3 fatty acids influence the extent to which the time\n      interval between each heart beat varies (heart rate variability; HRV). Low HRV is associated\n      with increased risk of sudden cardiac death (SCD). The purpose of this research is to\n      investigate the relationship between 24 hour parameters of HRV and blood omega-3 fatty acid\n      levels in patients who have recently commenced haemodialysis."
        }, 
        "brief_title": "Heart Rate Variability & Fatty Acid Status: Haemodialysis Patients", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Kidney Disease", 
        "condition_browse": {
            "mesh_term": [
                "Kidney Diseases", 
                "Renal Insufficiency, Chronic", 
                "Kidney Failure, Chronic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  CKD stage 5 commencing haemodialysis,\n\n          -  male or female,\n\n          -  aged 40-80 y,\n\n          -  written informed consent\n\n        Exclusion Criteria:\n\n          -  history of chronic liver disease or neuropathy, infection or antibiotics within the\n             last month."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "40 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients attending King's College Hospital and Guy's and St Thomas' Hospitals who have\n        recently commenced haemodialysis treatment."
            }
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02014792", 
            "org_study_id": "DNS9195677"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Haemodialysis", 
            "Heart rate variability", 
            "n-3 PUFA"
        ], 
        "lastchanged_date": "December 18, 2013", 
        "location": [
            {
                "contact": {
                    "email": "helen.maclaughlin@nhs.net", 
                    "last_name": "Helen MacLaughlin, PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "SE5 9RS"
                    }, 
                    "name": "King's College Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Helen MacLaughlin, PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Iain Macdougall, FRCP", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "wendy.hall@kcl.ac.uk", 
                    "last_name": "Wendy Hall, PhD", 
                    "phone": "(0)20 78484197"
                }, 
                "contact_backup": {
                    "email": "ana_margarida.pinto@kcl.ac.uk", 
                    "last_name": "Ana Pinto"
                }, 
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "SE1 9NH"
                    }, 
                    "name": "King's College London"
                }, 
                "investigator": [
                    {
                        "last_name": "Ana Pinto", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Tom Sanders, DSc", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_groups": "1", 
        "official_title": "Heart Rate Variability and Omega-3 Fatty Acid Status in Haemodialysis Patients: an Observational Pilot Study", 
        "other_outcome": [
            {
                "description": "Incidence of problems with dialysis access, inadequate urea reduction ratio, amount of excess oedematous fluid removed, serious adverse events", 
                "measure": "Complications of haemodialysis in first 6 weeks of starting treatment", 
                "safety_issue": "Yes", 
                "time_frame": "0-6 weeks after commencing haemodialysis"
            }, 
            {
                "description": "Food frequency questionnaire", 
                "measure": "Background dietary intakes", 
                "safety_issue": "No", 
                "time_frame": "6-10 weeks after commencing haemodialysis"
            }, 
            {
                "description": "Epworth Sleepiness scale and Berlin questionnaire, plus relevant medical history", 
                "measure": "History of sleep apnoea", 
                "safety_issue": "No", 
                "time_frame": "6-10 weeks after commencing haemodialysis"
            }, 
            {
                "measure": "Weight", 
                "safety_issue": "No", 
                "time_frame": "6-10 weeks after commencing haemodialysis"
            }, 
            {
                "measure": "Waist circumference", 
                "safety_issue": "No", 
                "time_frame": "6-10 weeks after commencing haemodialysis"
            }, 
            {
                "measure": "12 month average blood pressure", 
                "safety_issue": "No", 
                "time_frame": "12 months prior to commencing haemodialysis treatment"
            }, 
            {
                "measure": "Plasma lipids", 
                "safety_issue": "No", 
                "time_frame": "6-10 weeks after commencing haemodialysis"
            }, 
            {
                "measure": "C-reactive protein", 
                "safety_issue": "No", 
                "time_frame": "6-10 weeks after commencing haemodialysis"
            }, 
            {
                "description": "Sodium, potassium, calcium, phosphate", 
                "measure": "Serum electrolytes", 
                "safety_issue": "Yes", 
                "time_frame": "6-10 weeks after commencing haemodialysis"
            }
        ], 
        "overall_contact": {
            "email": "helen.maclaughlin@nhs.net", 
            "last_name": "Helen MacLaughlin, PhD", 
            "phone": "+44 (0)20 32996250"
        }, 
        "overall_official": [
            {
                "affiliation": "King's College London", 
                "last_name": "Wendy Hall, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "King's College Hospital NHS Trust", 
                "last_name": "Iain Macdougall, FRCP", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "UK: National Research Ethics Service", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Primary independent variable", 
                "measure": "Erythrocyte eicsapentaenoic acid (EPA) + docosahexaenoic acid (DHA) content (% weight of total fatty acids)", 
                "safety_issue": "No", 
                "time_frame": "6-10 wk after commencing haemodialysis treatment"
            }, 
            {
                "description": "Primary dependent variables. Triangular index and SDNN are indicators of overall variability", 
                "measure": "24 hour heart rate variability (Triangular index and SDNN)", 
                "safety_issue": "No", 
                "time_frame": "6-10 weeks after commencing haemodialysis treatment"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02014792"
        }, 
        "responsible_party": {
            "investigator_affiliation": "King's College London", 
            "investigator_full_name": "Dr Wendy Hall", 
            "investigator_title": "Lecturer in Nutritional Sciences", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Parameters of longer phase HRV: LF, VLF and SDANN", 
                "measure": "24 h heart rate variability - longer phase parameters", 
                "safety_issue": "No", 
                "time_frame": "6-10 weeks after commencing haemodialysis"
            }, 
            {
                "description": "RMSSD, pNN50, HF", 
                "measure": "24 h heart rate variability - short-phase parameters", 
                "safety_issue": "No", 
                "time_frame": "6-10 weeks after commencing haemodialysis"
            }, 
            {
                "description": "SDNN, Triangular index, LF, HF, VLF, SDANN, RMSSD, pNN50 calculating during nocturnal sleep-time", 
                "measure": "Nocturnal heart rate variability - all parameters", 
                "safety_issue": "No", 
                "time_frame": "6-10 weeks after commencing haemodialysis"
            }, 
            {
                "measure": "Plasma EPA+DHA content (% weight of total fatty acids)", 
                "safety_issue": "No", 
                "time_frame": "6-10 weeks after commencing haemodialysis6-10 weeks after commencing haemodialysis"
            }
        ], 
        "source": "King's College London", 
        "sponsors": {
            "collaborator": {
                "agency": "King's College Hospital NHS Trust", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "King's College London", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}